TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
77,080
|
80,515
|
75,490 |
| Financial expenses |
0
|
675
|
1,321 |
| Earnings before taxes |
8,264
|
-3,426
|
-2,343 |
| EBITDA |
8,920
|
-1,962
|
-1,028 |
| Total assets |
41,681
|
28,495
|
28,545 |
| Current assets |
37,880
|
24,172
|
25,001 |
| Current liabilities |
16,221
|
13,026
|
12,604 |
| Equity capital |
9,268
|
2,705
|
995 |
| - share capital |
206
|
203
|
189 |
| Employees (average) |
42
|
50
|
45 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
22.2%
|
9.5%
|
3.5% |
| Turnover per employee |
1,835
|
1,610
|
1,678 |
| Profit as a percentage of turnover |
10.7%
|
-4.3%
|
-3.1% |
| Return on assets (ROA) |
19.8%
|
-9.7%
|
-3.6% |
| Current ratio |
233.5%
|
185.6%
|
198.4% |
| Return on equity (ROE) |
89.2%
|
-126.7%
|
-235.5% |
| Change turnover |
-4,886
|
-331
|
12,042 |
| Change turnover % |
-6%
|
0%
|
19% |
| Chg. No. of employees |
-8
|
5
|
11 |
| Chg. No. of employees % |
-16%
|
11%
|
32% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.